SENS Research Foundation's 2015 Rejuvenation Biotechnology Conference Wraps Up on a High Note

MOUNTAIN VIEW, CA--(Marketwired - Aug 24, 2015) - The second annual Rejuvenation Biotechnology Conference successfully concluded Friday at the Hyatt Regency San Francisco Airport Hotel in Burlingame, CA. The conference, which is hosted by the SENS Research Foundation, brings together experts from research, academia, industry, policy, finance and regulatory fields to share ideas -- and the latest research and developments -- on diseases that are impacting the aging population on a global scale, such as Alzheimer's disease, cancer, and cardiovascular disease. The Rejuvenation Biotechnology Conference creates a forum for thought leaders from multiple disease communities to consider the wider potential of novel strategies for early intervention, while evaluating the feasibility of preventive and combinatorial medicine applications to treat all aging-related diseases.

"For the second year in a row, the Rejuvenation Biotechnology Conference achieved its mission of bringing together a global community to transform the treatment of age-related diseases," said Mike Kope, CEO of SENS Research Foundation. "With the explosive growth this past year in research into the underlying causes of the diseases of aging, we have an even greater opportunity to continue to accelerate the construction of the Rejuvenation Biotechnology industry. SENS Research Foundation will continue to grow our outreach efforts through conferences and general advocacy, because we believe that a world free of age-related disease is possible."

The theme for this year's Rejuvenation Biotechnology Conference was Bringing Together a Global Community to Transform the Treatment of Age-Related Diseases. Tracks included "Age-Related Diseases," "Therapeutic Approaches," and "Translation to Treatment," the latter of which included investigation into economics, investment, industry, regulatory issues, and the impact of digitization on healthcare.

The conference featured over 50 leading speakers from industry, academia, government, and the financial community. Highlights included keynoters Chas Bountra, SGC Oxford Chief Scientist, Professor of Translational Medicine, Nuffield Department of Clinical Medicine, and Associate Member, Department of Pharmacology, University of Oxford, who spoke on "Transforming the Discovery of New Medicines," and Frances Colón, Acting Science and Technology Adviser to the Secretary of State of the United States, who spoke on "Science and Technology for Diplomacy." Among the additional speakers were representatives of leading biotech firms including Sanofi, Sartorius Stedim, Fate Therapeutics, Biolatris, Sangamo BioSciences Inc., and Asterias Biotherapeutics, Inc. as well as CIRM, Stanford University, Scripps Institute and the Harvard Stem Cell Institute and other leading universities.

The conference also included a Poster session which featured 38 posters including 15 poster presentations by the SENS Research Foundation Summer Scholars. Poster award winners, who were announced Friday, included Le Zhang (first place), Amanda Paraluppi Bueno (second place) and Dee Luo (third place).

Conference sponsors included Sierra Sciences (Platinum Sponsor); International Anti-Aging Systems (Silver Sponsor); Peprotech, Life Extension, and Ageria (Bronze Sponsors); Lifespan.io and BGI (Booth Sponsors); Rejuvenation Research and Stem Cells Translational Medicine (Media Sponsors); and Sartorius Stedim Biotech (Poster Awards Sponsor).

"We're supremely grateful for the generous support of each of our sponsors," Kope added. "Without their dedicated belief in the mission of the SENS Research Foundation, the annual Rejuvenation Biotechnology Conference would not be possible."

SENS Research Foundation is working to lay the groundwork for new therapies that target and repair cellular and molecular damage that gradually accumulates in the body as a byproduct of metabolism, which is ultimately responsible for the pathology of aging. These treatments, which apply techniques from regenerative medicine to the damage of aging, are known as rejuvenation biotechnologies. This approach is in contrast to the great majority of existing treatments for age-related diseases, which either alter metabolism to prevent the accumulation of damage, or attempt to modulate the damage's downstream effects.

In addition to hosting the Rejuvenation Biotechnology Conference and other global events, SENS Research Foundation funds scientific research at some of the world's most prestigious universities and institutes, and conducts independent research at the SENS Research Foundation Research Center in Mountain View, California. The Foundation also offers a student program, SRF Education, to help guide the next generation of researchers focused on the development of rejuvenation biotechnologies. SRF Education operates a summer internship program, and is developing open online coursework.

For more information about SENS Research Foundation or to donate, visit http://www.sens.org. Sponsorships for the 2016 Rejuvenation Biotechnology Conference are also currently available; for more information, contact jerri.barrett@sens.org.

About SENS Research Foundation (SRF)
SENS Research Foundation is a 501(c)(3) nonprofit that works to research, develop, and promote comprehensive regenerative medicine solutions for the diseases of aging. SRF is focused on a damage repair paradigm for treating the diseases of aging, which it advances through scientific research, advocacy, and education. SENS Research Foundation supports research projects at universities and institutes around the world with the goal of curing such age-related diseases as macular degeneration, heart disease, cancer, and Alzheimer's disease. Educating the public and training researchers to support a growing regenerative medicine field are also major endeavors of the organization that are being accomplished though advocacy campaigns and educational programs. For more information, visit www.sens.org.